Related by context. All words. (Click for frequent words.) 69 PASI scores 68 gadolinium enhancing lesions 68 hip BMD 67 lumbar spine BMD 67 T2 lesions 67 P ≤ 66 oxycodone CR 66 HbA 1c levels 65 intravitreal injections 65 serum cortisol 65 serum phosphate 65 timepoints 65 viral titers 65 lactate dehydrogenase 65 mmHg diastolic 65 atheroma volume 65 elevated LDH 65 LV ejection fraction 65 carotid IMT 65 mL/min/#.# m 2 65 chemoradiation therapy 65 NMIBC 64 IOP lowering 64 SUVmax 64 binary restenosis 64 morphometric vertebral fractures 64 timepoint 64 tipranavir r 64 alanine aminotransferase ALT 64 lopinavir r arm 64 mcg BID 64 artery stenosis 64 nondiabetic patients 64 inflammatory lesions 64 advanced adenomas 64 serum aminotransferase levels 64 ibandronate 64 QTcF 64 gadolinium enhanced 64 albumin excretion rate 64 moderate renal impairment 64 deep venous thromboses 64 lumbar spine bone 64 CI -#.# 64 stent stenosis 64 symptomatic intracranial hemorrhage 63 Ishak fibrosis score 63 postoperative mortality 63 serum creatinine levels 63 serum urate levels 63 microvessel density 63 IFN beta 63 statistically significant p = 63 EDSS scores 63 undetectable HBV DNA 63 CIN3 63 spine BMD 63 WOMAC scores 63 SGPT 63 P = .# 63 postoperative morbidity 63 annualized relapse 63 Postoperatively 63 neutrophil counts 63 serum calcium levels 63 baseline LDH 63 transaminase levels 63 posttreatment 63 TT genotype 63 KRAS mutations occur 63 paraprotein 62 INCB# [003] 62 serum urate 62 verteporfin 62 corticosteroid dose 62 scintigraphic 62 Thal Dex 62 #.#/#.# mmHg [001] 62 ALT elevation 62 gross hematuria 62 colorectal adenoma 62 hepatic enzymes 62 intima media thickness 62 serum homocysteine 62 vitreous floaters 62 creatine phosphokinase 62 vitreous haze 62 HbA1C levels 62 ischemic lesions 62 serum lipid levels 62 HER2 expression 62 CsA 62 colorectal liver metastases 62 relapsed MM 62 aspartate aminotransferase AST 62 serum sodium levels 62 #.#/#.# mm Hg [003] 62 Natalizumab 62 PSA nadir 62 mcg QD 62 paricalcitol 62 β blockers 62 nonsignificant difference 62 pT3 62 daily subcutaneous injections 62 adenomatous 62 Crohn Disease Activity 62 prednisone prednisolone 62 extrapyramidal symptoms 62 recurrent glioblastoma multiforme 62 salivary flow 62 #OHD 62 postinjury 61 spirometric 61 SGOT 61 aminotransferases 61 #mg BID [001] 61 radiotherapy RT 61 HBeAg seroconversion 61 nonvertebral fracture 61 μmol L 61 MMSE score 61 FDG uptake 61 lesional 61 leukocyte counts 61 tolterodine ER 61 certolizumab 61 tracer uptake 61 elevated transaminases 61 glomerular filtration 61 interobserver agreement 61 serum estradiol 61 neoplasias 61 serum prostate 61 ALA PDT 61 tapentadol ER 61 grade squamous intraepithelial 61 ischemia driven 61 abacavir Ziagen 61 nonvertebral 61 total thyroidectomy 61 #Gy 61 STN DBS 61 adenoma recurrence 61 dosing frequency 61 serum magnesium 61 ASCUS 61 dose atorvastatin 61 asymptomatic carotid stenosis 61 thyroid carcinoma 61 femoral neck BMD 61 MADRS score 61 postprocedure 61 intact parathyroid hormone 61 PRADAXA #mg 61 HER2 amplification 61 lactate dehydrogenase LDH 61 intestinal polyps 61 unfractionated heparin UFH 61 specific antigen PSA 61 REYATAZ r arm 61 serum PSA 61 fluticasone salmeterol 61 timolol 61 -#.# ± [002] 61 caspofungin 61 aspartate aminotransferase 61 mucosal inflammation 61 renal cell carcinomas 61 biochemical relapse 61 lipid lowering agents 61 #mmHg [001] 61 -#.# mg dL [001] 61 p = .# [002] 61 atorvastatin #mg 61 detrusor overactivity 61 CIN2 + 60 fibrin deposition 60 serum testosterone 60 #mg/day [001] 60 complete cytogenetic response 60 mg p = 60 arthrography 60 anterior uveitis 60 plasma cortisol 60 antigen PSA levels 60 TPV r 60 Flu Cy 60 neurologic deficits 60 intraocular pressure IOP 60 colorectal neoplasms 60 leukocyte count 60 paresthesias 60 latanoprost 60 serum HBV DNA 60 glycated hemoglobin levels 60 alemtuzumab treated 60 clodronate 60 p = NS 60 statistically significant p 60 p = #.# [003] 60 cellularity 60 transaminase elevations 60 racemic albuterol 60 noncalcified 60 knee osteoarthritis OA 60 carotid stenosis 60 metastatic carcinoid tumors 60 neointimal 60 Plasma concentrations 60 bioavailable testosterone 60 mcg ml 60 posttraumatic arthritis 60 HOMA IR 60 nonmelanoma skin cancers 60 Serum creatinine 60 obstructive CAD 60 platelet reactivity 60 acromegalic patients 60 Stent thrombosis 60 eplerenone 60 plasma pharmacokinetics 60 gadolinium enhancing 60 lumbar disk herniation 60 desvenlafaxine succinate 60 multivariable adjusted 60 fasting plasma glucose FPG 60 virologic breakthrough 60 occlusive disease 60 metastatic malignant 60 CDAI score 60 interstitial fibrosis 60 ropivacaine 60 postoperative complication 60 hepatic fat 60 pmol L 60 foveal thickness 60 F FDG uptake 60 salmeterol fluticasone 60 serum triglycerides 60 F FDG PET 60 plasma homocysteine 60 postintervention 60 pCR 60 hematologic parameters 60 4mg/kg 60 leucopenia 60 abnormal ejaculation 60 parathyroidectomy 60 Pred Forte 60 CIMZIA TM certolizumab pegol 60 adjuvant cisplatin 60 osteolytic 60 PSADT 60 hippocampal volumes 60 conjunctival hyperemia 60 osteoporotic vertebral compression fractures 60 postop 60 bronchoalveolar lavage 60 AZT zidovudine Retrovir 60 haematologic 60 hyperacute 60 symptomatic intracranial 60 normal ULN 60 hemoglobin A1c levels 60 bullous 60 Stomatitis 60 colorectal carcinoma 60 systolic dysfunction 60 ventricular tachyarrhythmia 60 leukocytosis 60 postdose 60 genotypic resistance 60 transaminases 60 latent celiac disease 60 ARB telmisartan 60 severe exacerbations 60 CIMZIA ™ 60 HRCT 60 Subgroup analysis 60 neovascular 60 cinacalcet 60 kidney cysts 60 flutamide 60 GI motility 60 atrioventricular block 60 mcL 60 placebo p 60 liver histology 60 ulcerative lesions 60 serum concentrations 60 distensibility 60 hypervascular 60 tirofiban 60 macroalbuminuria 60 pamidronate 60 intravascular hemolysis 59 gastric adenocarcinoma 59 tissue oxygenation 59 eosinophilia 59 mg BID dose 59 NYHA functional class 59 isoproterenol 59 CC genotype 59 HBeAg negative patients 59 alanine aminotransferase 59 hyperhomocysteinemia 59 baseline FEV 59 hypervolemic 59 ximelagatran 59 Adenomas 59 unresectable HCC 59 neutrophil count 59 Index CDAI 59 stent binary restenosis 59 sUA 59 histologic subtype 59 severe periodontitis 59 serum ALT 59 mesangial 59 macrophage infiltration 59 pentoxifylline 59 invasive ductal 59 hyperintensity 59 nephrotoxicity 59 bezafibrate 59 detrusor 59 nasal polyposis 59 p = ns 59 endometrial thickness 59 Papillary 59 pg ml 59 detemir 59 skeletal metastases 59 prostaglandin analogues 59 DEXA scans 59 CCyR 59 fatty infiltration 59 plasma triglycerides 59 mutated KRAS 59 parenchymal 59 #.#mg/dL 59 rosuvastatin #mg 59 NAbs 59 rebleeding 59 hepatic insulin sensitivity 59 hematologic toxicity 59 #.#ng/ml 59 atypical ductal hyperplasia 59 5-FU/LV 59 euthyroid 59 femoral neck fracture 59 dyspareunia 59 microsatellite instability 59 isolated systolic hypertension 59 Doxil ® 59 definite stent thrombosis 59 postoperative inflammation 59 tertile 59 aminotransferase levels 59 hemoglobin Hb 59 intrahepatic 59 NNT = 59 liver enzymes ALT 59 Glypromate 59 NPH insulin 59 x ULN 59 dopaminergic therapy 59 protein excretion 59 NIHSS 59 perioperative mortality 59 exhaled NO 59 underwent surgical resection 59 platelet aggregation inhibitor 59 overt nephropathy 59 systemic corticosteroid 59 STN stimulation 59 acute cholecystitis 59 dosing cohort 59 titrated glipizide 59 mIU ml 59 pruritus itching 59 opacification 59 ß = 59 glycosylated hemoglobin HbA1c 59 placebo p = 59 unresectable tumors 59 invasive carcinomas 59 achieved statistical significance 59 rFSH 59 osteosarcomas 59 urine albumin 59 acetabular dysplasia 59 oral hypoglycemic agents 59 splenectomized 59 hemodynamically significant 59 HGPIN 59 nicardipine 59 left ventricular diastolic 59 elevated IOP 59 solifenacin 59 MMSE scores 59 rCBF 59 metaplasia 59 Target Lesion Revascularization TLR 59 reflux esophagitis 59 topically administered 59 anterior temporal 59 EDSS score 59 receiving ISENTRESS 59 mineral density 59 PANSS scores 59 neurocognitive function 59 nonvertebral fractures 59 intrathoracic 59 CYPHER ® 59 gastroduodenal 59 carotid plaque 59 inotropic 59 Squamous 59 adenoma detection 59 baseline HbA1c 59 candesartan cilexetil 59 Hypotension 59 zoledronate 59 tumor histology 59 sitaxsentan 59 alteplase 59 zonisamide SR 59 apolipoprotein B 59 dose dependently 59 prostate carcinoma 59 mitoxantrone plus 58 plasma creatinine 58 brain parenchyma 58 mmHg p = 58 sargramostim 58 cervical lymph nodes 58 Ejection Fraction 58 preoperative chemotherapy 58 nonfasting triglyceride levels 58 thyrotropin levels 58 hyperintense lesions 58 lymphocyte count 58 Operative mortality 58 retrograde ejaculation 58 statistical significance p 58 serum uric acid 58 coronary stenoses 58 urinary N telopeptide 58 myocardial viability 58 HBeAg 58 placebo dexamethasone 58 hip femoral neck 58 thyroglobulin 58 p ≤ 58 ventricular dilatation 58 tibiofemoral 58 hemorrhagic complications 58 patients undergoing CABG 58 incontinence episodes 58 HIV HCV coinfected 58 Fasting blood glucose 58 elevated troponin 58 mucinous 58 hepatorenal syndrome 58 mm Hg systolic 58 highest tertile 58 -#.# log# 58 LV dysfunction 58 methotrexate monotherapy 58 mg/m2 dose 58 Lumbar spine 58 intravenous bisphosphonates 58 Legg Calvé Perthes disease 58 brachial artery flow 58 systolic blood pressures 58 cystoscopic 58 Cypher Stent 58 radiographic progression 58 Preoperatively 58 periocular 58 8mg/kg 58 tacrolimus ointment 58 tertiles 58 preoperative PSA 58 deferoxamine 58 vestibular schwannomas 58 triacylglycerol concentrations 58 treated nonsurgically 58 urinary excretion 58 hematologic abnormalities 58 β blocker 58 bivalirudin monotherapy 58 tPSA 58 glycosylated hemoglobin levels 58 plasma viremia 58 nonmetastatic prostate cancer 58 mmol kg 58 anemia hemoglobin 58 pretest probability 58 ejection fractions 58 Evaluable 58 pooled comparator 58 -#.# mg dL [002] 58 POAG 58 debulking surgery 58 N telopeptide 58 hypophosphatemia 58 serum PTH 58 pulmonary dysfunction 58 cortical atrophy 58 HDRS 58 umol L 58 WOMAC pain 58 everolimus eluting stents 58 postoperative bleeding 58 â ‰ ¥ 58 comparator arm 58 mg TID 58 tumoral 58 adrenalectomy 58 histological subtype 58 atherosclerotic renal artery stenosis 58 T1 weighted images 58 intravenous diuretics 58 pulmonary arterial 58 micafungin 58 CYPHER Stent 58 intima media thickness IMT 58 ALT normalization 58 Clinically significant 58 CLINICAL STUDIES 58 mineral density BMD 58 KRAS mutant tumors 58 atazanavir ritonavir 58 5 HT2C receptor 58 sonographically 58 endometrial hyperplasia 58 renal cysts 58 mycophenolate mofetil MMF 58 triiodothyronine 58 urothelial carcinoma 58 PAOD 58 microbleeds 58 lung edema 58 hyperalgesia 58 serum HCV RNA 58 reduce serum phosphate 58 CI #.#-#.# [001] 58 epistaxis 58 Parathyroid hormone 58 Xalatan R 58 echogenicity 58 arterial thromboembolic events 58 oral anticoagulant therapy 58 prolonged QT interval 58 graft occlusion 58 beta interferons 58 proliferative diabetic retinopathy 58 steroid dexamethasone 58 pouchitis 58 FDA defined valvulopathy 58 uM 58 Aloxi injection 58 clinically meaningful improvements 58 pelvic irradiation 58 achieved CCyR 58 μg mL 58 mRNA expression 58 isoprostane 58 Bone density 58 seroconverted 58 dose Iluvien 58 lowest tertile 58 tortuosity 58 TNFalpha 58 nadroparin 58 LPV r 58 radical prostatectomy RP 58 HbA 1c 58 androgen suppression 58 FOLFOX6 58 homozygotes 58 μg kg 58 alpha1 58 non menstrual pelvic 58 generalized edema 58 GnRH agonists 58 infarcts 58 nodal metastasis 58 comorbid depression 58 fluticasone propionate FP 58 clinically meaningful reductions 58 malignant ascites 58 iPTH 58 serum phosphate levels 58 parasitemia 58 polypoid 58 piperacillin tazobactam 58 ipsilateral 58 neuritic 58 HAQ DI 58 recurrent DVT 58 Impaired glucose tolerance 58 histologically proven 58 perfusion defects 58 Endometrial 58 serum bicarbonate 58 nonproliferative 58 adjunctive placebo 58 preintervention 58 zotarolimus 58 pT2 58 imiquimod cream 58 urinary albumin 58 hormone receptor negative 58 p = .# [001] 58 hemoglobin A1c HbA1c 58 allogeneic HSCT 58 ß amyloid 58 8 OHdG 58 oral clodronate 58 achieved ACR# 58 akinesia 58 liver metastasis 58 virologic response 58 NIH CPSI 58 FOLPI 58 ATACAND 58 left ventricular systolic 58 moderately emetogenic 58 perioperative complications 58 enzyme elevations 58 myelosuppressive 58 skeletally mature patients 58 isoenzyme 58 NNRTI resistance 58 PsA 58 hyperphenylalaninemia HPA due 58 blood phenylalanine Phe 58 biliary tract cancers 58 afterload 58 SGRQ 58 ventricular enlargement 58 submucosal 58 Secondary endpoints included 58 albumin excretion 58 CrCl 58 NSTE ACS 58 brimonidine 58 Cystatin C 58 ALT elevations 58 percutaneous vertebroplasty 58 anagrelide 58 urate lowering therapy 58 inflammatory biomarkers 58 advanced adenoma 58 airway hyper responsiveness 58 troponin T 58 mIU L 57 Patency 57 bacteriuria 57 myeloperoxidase 57 Breslow thickness 57 macular thickness 57 coronary calcification 57 CK # plasma concentrations 57 infraspinatus 57 nonalcoholic steatohepatitis NASH 57 node metastases 57 mediastinal 57 urinary oxalate 57 antifibrinolytic 57 ritonavir boosted 57 serum parathyroid hormone 57 Navelbine 57 % CI #.#-#.# [007] 57 pegylated liposomal doxorubicin 57 nonfatal MI 57 coronary stenosis 57 creatinine ratio 57 leiomyomas 57 chlorambucil 57 postoperative infections 57 alanine transaminase 57 primary patency 57 normothermic 57 metabolic parameters 57 reinfarction 57 biochemical recurrence 57 fibrosis progression 57 receiving XGEVA 57 subacromial 57 ascending aortic 57 anastomotic leak 57 EBRT 57 mg kg dose 57 Leydig cell 57 Pyratine XR TM 57 biopsy Gleason 57 ALT flares 57 insulin detemir 57 CP CPPS 57 risedronate Actonel 57 tolvaptan 57 neurocognitive deficits 57 % CI #.#-#.# [003] 57 polyposis 57 ertapenem 57 affective psychosis 57 Fasting plasma glucose 57 #mg/day [002] 57 multivariable analysis 57 intravenous bolus injection 57 follicular lymphomas 57 oxyhemoglobin 57 dose cohort 57 ductal lobular 57 fasting plasma 57 Zyclara 57 mTSS 57 % Confidence Interval 57 hypercholesterolaemia 57 Elitek 57 mmHg systolic 57 retinal thickness 57 octreotide LAR 57 pg mL 57 creatine kinase MB 57 symptomatic VTE 57 receiving prophylactic anticoagulation 57 primary hyperparathyroidism 57 ARCALYST ® 57 ejection fraction EF 57 lumen diameter 57 LHRH agonists 57 upper GI tract 57 Hematologic 57 interleukin IL -6 57 RLAI 57 nonobstructive CAD 57 choroidal neovascularization CNV 57 ALVESCO 57 Apolipoprotein B 57 histologically confirmed 57 endometrial carcinoma 57 CVD mortality 57 corticosteroid therapy 57 chondral 57 pulmonary vascular 57 CYP#D# inhibitor 57 GLIADEL R Wafer 57 hepatocellular 57 capillary density 57 trastuzumab Herceptin ® 57 hip resurfacing arthroplasty 57 nonischemic 57 severe mitral regurgitation 57 intratumoral 57 mL sec 57 elevated creatinine 57 glycated hemoglobin HbA1c 57 immunoreactivity 57 tamoxifen Nolvadex ® 57 locoregional recurrence 57 IPSS 57 BoNTA 57 HBV DNA 57 arteriolar 57 cobiprostone 57 HIV lipodystrophy 57 TEAEs 57 CTEPH 57 myocardial reperfusion 57 PaO 2 57 cranial irradiation 57 intraoperative complications 57 diastolic BP 57 Histologic 57 hemoglobin concentrations 57 GERD symptom 57 conventional DMARDs 57 PREZISTA r arm 57 idiopathic PAH 57 IL 1ß 57 hypoperfusion 57 confidence interval #.#-#.# 57 metachronous 57 hyperplastic 57 hyperemia 57 antiandrogen 57 Insulin sensitivity 57 cerebrovascular events 57 ethambutol 57 MS relapses 57 rheumatoid factor 57 leuprorelin 57 arteriography 57 interobserver 57 prolactin levels 57 mRS 57 CIN3 + 57 serum albumin 57 fractional shortening 57 lispro 57 ULORIC 57 T2 weighted images 57 mmol l 57 computed tomographic scans 57 seropositive patients 57 fasting glucose levels 57 hypogonadal 57 oral ibandronate 57 ADAS Cog 57 median survivals 57 Nonspecific 57 FOLFOX4 57 pulmonary exacerbations 57 pulmonary exacerbation 57 TMP SMX 57 vastus lateralis 57 FUSILEV enhances 57 intravesical therapy 57 interobserver reliability 57 antihypertensive therapy 57 AGILECT R 57 fibrinolysis 57 CDAI 57 postmenopausal osteoporotic women 57 ovarian carcinoma 57 nonmalignant 57 paclitaxel eluting stents 57 TKAs 57 creatinine levels 57 indinavir 57 carotid artery blockage 57 distal colon 57 db db mice 57 XIENCE V PROMUS Stent 57 pulmonary angiography 57 serum retinol 57 papillary renal cell carcinoma 57 PERLANE 57 thrombocytopenic 57 #F FDG 57 pulmonary capillary wedge 57 neurologic symptoms 57 HER2 overexpression 57 diastolic blood pressures 57 PLX STROKE targeting 57 neutropenic sepsis 57 salmeterol HFA MDI 57 #q# deletion syndrome 57 ° preoperatively 57 alendronate Fosamax 57 recurrent venous thromboembolism 57 elevated ALT 57 choroidal neovascularization 57 cardiac repolarization 57 lipid lowering therapies 57 #mmHg [002] 57 hippocampal atrophy 57 plasma renin 57 hematological toxicity 57 virological response 57 alveolar bone loss 57 OAB symptoms 57 infarct size 57 recurrent UTI 57 hyperprolactinemia 57 response CCyR 57 NovoSeven ® 57 TMC# r 57 secondary hyperparathyroidism 57 CIMZIA TM 57 Retreatment 57 osteopenic 57 #.#mmHg 57 venous reflux 57 HeFH 57 oral antidiabetic medication 57 abacavir lamivudine 57 varices 57 FIRMAGON 57 Kepivance 57 ADPKD 57 oesophagitis 57 ug kg 57 pegIFN 57 #mg/m# [001] 57 T1a 57 syncope fainting 57 histologically 57 simvastatin ezetimibe 57 receiving highly emetogenic 57 ß blockers 57 E selectin 57 cGy 57 sirolimus eluting stents 57 squamous histology 57 retinal edema 57 Intravitreal 57 Psoriasis Area 57 endothelium dependent 57 Heavy menstrual bleeding 57 neointimal hyperplasia 57 headache nasopharyngitis 57 hypercalcaemia 57 DAS# CRP 57 artery occlusion 57 serum triglyceride levels 57 histopathologic findings 57 pericardial effusion 57 onset diabetes mellitus 57 lumbar disc herniation 57 hsCRP levels 57 heterozygotes 57 splenic 57 NATRECOR ® 57 growth hormone secretion 57 mcg albinterferon alfa 2b 57 metastatic lesions 57 central corneal thickness 57 elevated triglyceride levels 57 PANSS total 57 Barrett esophagus BE 57 myocardial infarct size 57 Pemetrexed 57 GHRH 57 IFN α 57 liver transaminases 57 reoperations 57 enlarged spleens 57 neutropaenia 57 pyridostigmine 57 benign nodules 57 apnea hypopnea 57 bortezomib refractory 57 luminal diameter 57 amifostine 57 intravenous thrombolysis 57 hepatocellular carcinomas 57 polyp recurrence 56 leukopenia 56 adnexal mass 56 crossclamp 56 log# copies mL 56 doxorubicin docetaxel 56 KTP laser 56 mutated K ras 56 HbA1c levels 56 MGUS 56 Posaconazole 56 UPDRS motor 56 experienced virologic failure 56 aPTT 56 #mg QD [001] 56 ACR# responses 56 myocardial fibrosis 56 systemic antifungal 56 Visual acuity 56 Viral load 56 carcinoids 56 CD# upregulation 56 ghrelin concentrations 56 intravenous dosing 56 risk reducing salpingo 56 perioperatively 56 sweat chloride 56 knee extensor 56 hepatic lesions 56 hepatic resection 56 epoetin alpha 56 EpCAM expression 56 Score IPSS 56 contralateral 56 % CI #.#-#.# [001] 56 varus deformity 56 hypertrophic scars 56 Nocturia 56 dexrazoxane 56 MGd 56 Atherosclerotic 56 elevated serum creatinine 56 FluCAM arm 56 erythrocyte sedimentation rate 56 tumor perfusion 56 carotid artery stenting CAS 56 1mg dose 56 multivessel disease 56 Drug eluting stent 56 posterior vitreous detachment 56 thromboembolic events 56 dysuria 56 cough dyspnea 56 creatinine clearance 56 myocardial necrosis 56 hypofractionated radiation